Jul 30, 2026 06:30AM
Jul 21, 2026 07:00AM
Jul 21, 2026 07:00AM
Jul 7, 2026 07:00AM
Jul 7, 2026 07:00AM
Jun 13, 2026 09:00AM
Jun 13, 2026 09:00AM Agios Showcases RISE UP Phase 3 Results at EHA 2026 Plenary Session Reinforcing Strong Anti-Hemolytic Profile of Mitapivat in Sickle Cell Disease
Jun 1, 2026 05:00AM
Jun 1, 2026 05:00AM
May 29, 2026 07:00AM
May 29, 2026 07:00AM
May 22, 2026 09:15AM
May 22, 2026 09:15AM
May 12, 2026 09:32AM Agios submits application for accelerated approval of mitapivat in sickle cell
May 12, 2026 09:31AM
May 12, 2026 09:30AM
May 12, 2026 09:30AM
Apr 29, 2026 06:30AM
Apr 21, 2026 06:41AM
Mar 31, 2026 01:08PM
Mar 31, 2026 08:54AM Stifel: 'we think FULC as a soon-to-be ph3 SCD company is significantly under-appreciated'
Mar 31, 2026 08:33AM
Mar 31, 2026 07:01AM
Mar 31, 2026 07:00AM
Mar 2, 2026 07:00AM
Feb 12, 2026 11:40AM
Feb 12, 2026 06:30AM
Jan 12, 2026 07:03AM Agios outlines 2026 milestones for rare disease drug portfolio
Jan 12, 2026 07:00AM
Dec 26, 2025 07:01AM
Dec 24, 2025 12:28PM
Dec 23, 2025 07:45PM
Dec 23, 2025 07:45PM
Dec 9, 2025 06:56AM
Dec 8, 2025 07:02AM Agios awaits FDA decision on mitapivat for thalassemia treatment
Dec 8, 2025 07:00AM
Nov 25, 2025 07:31AM
Nov 20, 2025 06:19AM
Nov 19, 2025 01:53PM
Nov 19, 2025 07:00AM
Nov 19, 2025 07:00AM
Nov 3, 2025 09:01AM Agios to Present New Mitapivat Data in Rare Blood Disorders at 67th ASH Annual Meeting and Exposition
Oct 30, 2025 06:30AM
Oct 17, 2025 08:01AM
Oct 17, 2025 08:00AM
Sep 5, 2025 06:44AM
Sep 5, 2025 05:02AM
Sep 4, 2025 12:08PM
Sep 4, 2025 10:23AM Agios Pharma (AGIO) PT Lowered to $51 at BofA Securities
Sep 4, 2025 07:00AM

328,148 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All